| | |

Tag search: "Breast Cancer"

Promoting health through the life course

For women, baby aspirin may reduce risk of breast cancer

Researchers studied data on 57,164 women, mostly in their early 60s, who had no history of cancer. About 23% of them took a low dose aspirin. About 11% of them took a full strength aspirin and 10% took a COX-2 inhibitor or another nonsteroidal anti-inflammatory drug each week. Over seven years 1,457 women got breast cancer and those taking low-dose aspirin were 16% less likely to develop any type of breast cancer 

May 13, 2017
Washington Post

Most doctors' breast cancer advice may be out of date

A new study says that women may be getting contradictory advice on when they should start having a regular mammogram. The study found some doctors suggesting between the ages of 40 and 44 (81%) and others between the ages of 45 and 49 (89%), advice with contradicts U.S. Federal recommendations which say start at age 50

April 10, 2017
Time

Are some breast cancer patients getting too much radiation?

More than half of older American women with early breast cancer may be getting more radiation therapy than needed, which significantly boosts medical costs, a new study indicates

March 15, 2017
CBC News

E-therapy tied to better body image, intimacy for breast cancer survivors

Internet-based psychotherapy focused on changing behaviour may be tied to improved body image and sexual functioning in breast cancer survivors, a recent study suggests

March 2, 2017
Reuters

Breast cancer costs low-income women more jobs

Poor women undergoing breast cancer treatment are four times more likely to lose their jobs than their high-income peers, a new study says

February 28, 2017
Reuters

Non communicable diseases

U.S. physicians move to more flexible mammogram schedule

Women at average risk for breast cancer should be offered screening mammograms every year or two starting at age 40 and they should start regular screening no later than age 50, an influential U.S. group of obstetricians and gynaecologists said. Amid divided expert opinions on whether more screenings are beneficial, the American College of Obstetricians and Gynaecologists, which previously recommended yearly screenings starting at age 40, wants to stress shared decision-making between women and their doctors based on their personal preferences in the new, more flexible schedule

June 22, 2017
Reuters

BRCA1, BRCA2 study provides new clarity on breast cancer risk for carriers of gene mutations

A new study has provided a better understanding of the risk of breast cancer for carriers of the BRCA1 and BRCA2 gene mutation, which points to the need for early identification and lifelong monitoring of the disease. The study published in the Journal of the American Medical Association involved almost 10,000 women in Australia, the United States and Europe over 20 years, and found that those with the BRCA1 mutation had, on average, a 72 per cent risk of developing breast cancer by the age of 80. For those with the BRCA2 mutation, the risk of breast cancer was 69 per cent and the lifetime risk of ovarian cancer was 17 per cent

June 20, 2017
ABC.Net

Ghana Records 60,000 Cancer Cases Annually - Dr Joel Yarney

Dr Joel Yarney, the Head of the Medical Centre for Radiotherapy and Nuclear Medicine at the Korle-Bu Teaching Hospital, said about 60,000 cancer cases are recorded by Ghana annually. He said out of this figure 2,500 were breast cancer cases, and this requires that urgent action be taken to ensure prevention and treatment, along with improvements in quality of care

June 13, 2017
Peace FM

The trauma of a breast cancer diagnosis can have cognitive effects

The mental fog often experienced by breast cancer patients after chemotherapy might be due more to post-traumatic stress than to cancer drugs, a new study suggests. The study finds that similar symptoms have been reported by breast cancer patients who have not started their chemotherapy yet and even by those whose treatment did not include chemotherapy. The study concluded that PTSD symptoms, not the treatment, were the principal cause

May 29, 2017
Reuters

Health systems

How Trump has made the Department of Health and Human Services a center of false science on cont...

President Trump and Health and Human Services Secretary Tom Price have stocked the corridors of health policy with purveyors of conclusively debunked claptrap about contraception, abortion, pregnancy and women’s reproductive health generally. Among their themes is that condoms don’t protect against HIV or other sexually transmitted diseases and that abortions and contraceptives cause breast cancer, miscarriages and infertility. None of these assertions is true

June 15, 2017
Los Angeles Times
June 14, 2017
New England Journal of Medicine

UK will pay for Roche breast cancer drug at centre of price row

A Roche breast cancer drug at the centre of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service. Kadcyla, which can prolong the lives of some women with advanced disease, has been a battle-ground for campaigners wanting better access to modern cancer drugs, with 115,000 people signing a petition demanding its availability. The National Institute for Health and Care Excellence said it could now recommend funding for Kadcyla, following the commercial access arrangement with Roche

June 15, 2017
Reuters

'I thought cancer was a disease for the elderly': tackling Nigeria's 80% mortality rate

NGO’s are working hard to change cancer treatment in Nigeria, despite poor facilities and a lack of awareness. The Guardian reports on the work of the Nigeria-based Health and Psychological Trust Centre, known as Project Pink Blue, which is trying to bring best practice cancer care to Abuja

March 20, 2017
The Guardian

Communicable diseases

More people could benefit from BRCA breast cancer drugs

A study by Serena Nik-Zainal and her team, at the Sanger Institute, found that thousands of breast cancers share biochemical similarities to cases caused by BRCA1 and BRCA2 mutations. A type of drug called PARP inhibitors can be used to treat these cancers and were specifically designed to target tumours with defects in these genes. But Nik-Zainal’s findings suggest 8,000 more people with breast cancer may also respond to these drugs

March 13, 2017
New Scientist

Mediterranean diet may reduce risk of form of breast cancer – study

Eating plenty of nuts, fruit and fish may cut the risk of getting oestrogen-receptor negative cancer, a Dutch research finds

March 6, 2017
The Guardian, The Times, Daily Mail